vs
Side-by-side financial comparison of BCB BANCORP INC (BCBP) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $26.2M, roughly 1.2× BCB BANCORP INC). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -49.7%, a 17.5% gap on every dollar of revenue. On growth, BCB BANCORP INC posted the faster year-over-year revenue change (13.1% vs -4.5%). BCB BANCORP INC produced more free cash flow last quarter ($34.9M vs $25.0K). Over the past eight quarters, BCB BANCORP INC's revenue compounded faster (1.8% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
BCBP vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $26.2M | $31.1M |
| Net Profit | $-12.0M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | -71.9% | -9.9% |
| Net Margin | -49.7% | -32.1% |
| Revenue YoY | 13.1% | -4.5% |
| Net Profit YoY | -467.6% | -52.0% |
| EPS (diluted) | $-0.73 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.2M | — | ||
| Q3 25 | $26.5M | $31.1M | ||
| Q2 25 | $25.2M | — | ||
| Q1 25 | $23.8M | $35.2M | ||
| Q4 24 | $23.1M | $32.6M | ||
| Q3 24 | $26.2M | $24.7M | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $25.3M | $35.7M |
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $4.3M | $-10.0M | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $-8.3M | $-14.8M | ||
| Q4 24 | $3.3M | $-6.6M | ||
| Q3 24 | $6.7M | $-16.2M | ||
| Q2 24 | $2.8M | — | ||
| Q1 24 | $5.9M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | -71.9% | — | ||
| Q3 25 | 21.9% | -9.9% | ||
| Q2 25 | 19.9% | — | ||
| Q1 25 | -49.2% | -25.7% | ||
| Q4 24 | 19.9% | -6.0% | ||
| Q3 24 | 35.7% | -46.9% | ||
| Q2 24 | 19.5% | — | ||
| Q1 24 | 33.0% | -2.5% |
| Q4 25 | -49.7% | — | ||
| Q3 25 | 16.1% | -32.1% | ||
| Q2 25 | 14.2% | — | ||
| Q1 25 | -35.0% | -42.0% | ||
| Q4 24 | 14.1% | -20.2% | ||
| Q3 24 | 25.5% | -65.7% | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 23.2% | 43.8% |
| Q4 25 | $-0.73 | — | ||
| Q3 25 | $0.22 | $-0.29 | ||
| Q2 25 | $0.18 | — | ||
| Q1 25 | $-0.51 | $-0.47 | ||
| Q4 24 | $0.17 | $-0.25 | ||
| Q3 24 | $0.36 | $-0.53 | ||
| Q2 24 | $0.14 | — | ||
| Q1 24 | $0.32 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $304.3M | $-10.5M |
| Total Assets | $3.3B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $304.3M | — | ||
| Q3 25 | $318.5M | $-10.5M | ||
| Q2 25 | $315.7M | — | ||
| Q1 25 | $314.7M | $2.2M | ||
| Q4 24 | $323.9M | $15.4M | ||
| Q3 24 | $328.1M | $-3.9M | ||
| Q2 24 | $320.7M | — | ||
| Q1 24 | $320.1M | $17.7M |
| Q4 25 | $3.3B | — | ||
| Q3 25 | $3.4B | $235.2M | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | $3.5B | $237.7M | ||
| Q4 24 | $3.6B | $255.4M | ||
| Q3 24 | $3.6B | $246.8M | ||
| Q2 24 | $3.8B | — | ||
| Q1 24 | $3.8B | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.9M | $1.8M |
| Free Cash FlowOCF − Capex | $34.9M | $25.0K |
| FCF MarginFCF / Revenue | 133.3% | 0.1% |
| Capex IntensityCapex / Revenue | 4.0% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $58.2M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.9M | — | ||
| Q3 25 | $8.7M | $1.8M | ||
| Q2 25 | $10.3M | — | ||
| Q1 25 | $5.0M | $1.2M | ||
| Q4 24 | $67.7M | $-6.1M | ||
| Q3 24 | $43.5M | $-613.0K | ||
| Q2 24 | $8.1M | — | ||
| Q1 24 | $8.3M | $-1.4M |
| Q4 25 | $34.9M | — | ||
| Q3 25 | $8.5M | $25.0K | ||
| Q2 25 | $10.2M | — | ||
| Q1 25 | $4.7M | $-4.3M | ||
| Q4 24 | $66.5M | $-8.6M | ||
| Q3 24 | $43.4M | $-4.0M | ||
| Q2 24 | $8.1M | — | ||
| Q1 24 | $8.1M | $-7.8M |
| Q4 25 | 133.3% | — | ||
| Q3 25 | 32.0% | 0.1% | ||
| Q2 25 | 40.4% | — | ||
| Q1 25 | 19.8% | -12.1% | ||
| Q4 24 | 287.5% | -26.3% | ||
| Q3 24 | 166.0% | -16.3% | ||
| Q2 24 | 39.6% | — | ||
| Q1 24 | 32.3% | -21.8% |
| Q4 25 | 4.0% | — | ||
| Q3 25 | 1.1% | 5.6% | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 1.2% | 15.5% | ||
| Q4 24 | 5.3% | 7.5% | ||
| Q3 24 | 0.3% | 13.9% | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.6% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | 2.05× | — | ||
| Q2 25 | 2.90× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.70× | — | ||
| Q3 24 | 6.53× | — | ||
| Q2 24 | 2.88× | — | ||
| Q1 24 | 1.41× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCBP
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
